logo

TAK

Takeda Pharmaceutical·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

TAK fundamentals

Takeda Pharmaceutical (TAK) expects to report earnings on Oct 30, 2025, with estimated revenue of 7.65B (YoY 0.00%), and EPS at -- (YoY 0.00%).
Revenue estimate / YoY
7.65B
0.00%
EPS estimate / YoY
--
0.00%
Report date
Oct 30, 2025
TAK Earnings Call Summary for Q2,2026
  • VYVANSE Impact Waning: FY25 H1 LOE peak, FY26 growth acceleration with 3 new launches.
  • ENTYVIO Growth Revised: FY25 growth 6% (vs. 9%) due to competition, but Pen QoQ +20% in U.S.
  • FX Headwinds: Euro volatility reduces FY25 core OP by ~JPY 10 billion.
  • Innovent Deal Potential: 3 assets targeting $40+ billion lung/CRC market; Phase III data expected Q4 FY25.
  • R&D Efficiency: 90%+ R&D programs enabled by AI by FY26; JPY 27.4 billion H1 restructuring savings.
EPS
Revenue

Revenue & Expenses

TAK has released its 2026 Q2 earnings report, with revenue of 7.52B, reflecting a YoY change of -8.40%, and net profit of -79.27M, showing a YoY change of -112.33%. The Sankey diagram below clearly presents TAK's revenue sources and cost distribution.

Key Indicators

Takeda Pharmaceutical (TAK) key financial stats and ratios, covering profitability, financial health, and leverage.
Takeda Pharmaceutical (TAK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Takeda Pharmaceutical (TAK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Takeda Pharmaceutical (TAK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Takeda Pharmaceutical (TAK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Takeda Pharmaceutical (TAK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield